Kryron Aluminum Alloy Successfully Passes Ballistic Protection Tests

Controlled tests have been successfully performed on Bourque Industries’ Kryron aluminum alloy to determine the ballistic protection ability and battle-worthiness of the material.

Kryron metal super alloy is a suitable material for ballistic armor line. The tests show the Kryron alloys’ multi-impact capability for lightweight armor protection.

The Kryron Terminator armor is highly durable and lighter than conventional personal protection ceramic armor plates. It prevents rebounding of objects, spalls and shatters. The armor provides industry’s best ballistic protection and offers excellent multi-impact capability by preventing many high-speed and large-caliber rounds at very short ranges. Significant weight savings are also achieved when compared to existing protection armor plates.

The company also showed the proof-of-concept for US military helicopters and land-based tactical vehicles.

Bourque Industries’ founder and Kryron’s inventor, John M. Bourque pointed out that the Kryron is the most excellent ballistic armor material available in the market and is the best option for developing advanced armor products for sea, land and air.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). Kryron Aluminum Alloy Successfully Passes Ballistic Protection Tests. AZoM. Retrieved on September 24, 2024 from https://www.azom.com/news.aspx?newsID=29287.

  • MLA

    Chai, Cameron. "Kryron Aluminum Alloy Successfully Passes Ballistic Protection Tests". AZoM. 24 September 2024. <https://www.azom.com/news.aspx?newsID=29287>.

  • Chicago

    Chai, Cameron. "Kryron Aluminum Alloy Successfully Passes Ballistic Protection Tests". AZoM. https://www.azom.com/news.aspx?newsID=29287. (accessed September 24, 2024).

  • Harvard

    Chai, Cameron. 2019. Kryron Aluminum Alloy Successfully Passes Ballistic Protection Tests. AZoM, viewed 24 September 2024, https://www.azom.com/news.aspx?newsID=29287.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.